Showing results (21-30 of 195) with videos related to
Sort By:
Pageof 20
Transplantation Proceedings|August 5, 2009
Regulatory T cells in transplantation: what we know and what we do not knowM Y Yeung, M H SayeghEuropean Journal of Clinical Investigation|October 1, 1989
Metabolic effects of biosynthetic human proinsulin in type 2 diabetes mellitusR Klauser, R Prager, B Watschinger, et al.Transplantation Proceedings|March 26, 2004
The antagonism of calcineurin inhibitors and costimulatory blockers: fact or fiction?A Izawa, M H Sayegh, A ChandrakerPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 26, 2001
Involvement of the direct and indirect pathways of allorecognition in tolerance inductionK L Womer, M H Sayegh, H AuchinclossInternational Reviews of Immunology|December 30, 1999
Blocking costimulatory signals to induce transplantation tolerance and prevent autoimmune diseaseS Khoury, M H Sayegh, L A TurkaCurrent Drug Targets|July 18, 2003
P-glycoprotein--a novel therapeutic target for immunomodulation in clinical transplantation and autoimmunity?S Pendse, M H Sayegh, M H FrankCurrent Opinion in Urology|April 29, 2000
The role of costimulatory molecules as targets for new immunosuppressives in transplantationK Kishimoto, V M Dong, M H SayeghJournal of Immunology (Baltimore, Md. : 1950)|May 7, 1998
Mechanisms of acquired thymic tolerance in vivo: intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergyW Chen, M H Sayegh, S J KhouryNephron|January 1, 1989
Secondary hypersplenism due to Caroli syndrome complicating immunosuppression in a renal allograft recipientB Watschinger, B Schwaighofer, F Wrba, et al.Wiener Klinische Wochenschrift|September 9, 1988
[Retrospective analysis of results and complications following kidney transplantation in diabetic nephropathy--a challenge for the future]B Watschinger, A Sonnleitner, M Schwarz, et al.Pageof 20